ATE259505T1 - Test zur quantifizierung von arthritiszustanden - Google Patents

Test zur quantifizierung von arthritiszustanden

Info

Publication number
ATE259505T1
ATE259505T1 AT97918970T AT97918970T ATE259505T1 AT E259505 T1 ATE259505 T1 AT E259505T1 AT 97918970 T AT97918970 T AT 97918970T AT 97918970 T AT97918970 T AT 97918970T AT E259505 T1 ATE259505 T1 AT E259505T1
Authority
AT
Austria
Prior art keywords
adp
molecular weight
body fluid
fluid sample
measure
Prior art date
Application number
AT97918970T
Other languages
English (en)
Inventor
Vishwas Ganu
Original Assignee
Novartis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Pharma Gmbh filed Critical Novartis Pharma Gmbh
Application granted granted Critical
Publication of ATE259505T1 publication Critical patent/ATE259505T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/105—Osteoarthritis, e.g. cartilage alteration, hypertrophy of bone
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25125—Digestion or removing interfering materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/2525—Stabilizing or preserving
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
    • Y10T436/255—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.] including use of a solid sorbent, semipermeable membrane, or liquid extraction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT97918970T 1996-08-15 1997-08-08 Test zur quantifizierung von arthritiszustanden ATE259505T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2404196P 1996-08-15 1996-08-15
PCT/EP1997/004316 WO1998007035A1 (en) 1996-08-15 1997-08-08 Assay for quantifying arthritic conditions

Publications (1)

Publication Number Publication Date
ATE259505T1 true ATE259505T1 (de) 2004-02-15

Family

ID=21818539

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97918970T ATE259505T1 (de) 1996-08-15 1997-08-08 Test zur quantifizierung von arthritiszustanden

Country Status (7)

Country Link
US (1) US6589755B1 (de)
EP (1) EP0922225B1 (de)
JP (1) JP4189033B2 (de)
AT (1) ATE259505T1 (de)
AU (1) AU4298297A (de)
DE (1) DE69727582T2 (de)
WO (1) WO1998007035A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2788603B1 (fr) * 1999-01-20 2001-04-13 Covalab PROCEDE D'IMMUNOANALYSE D'UNE PROTEINE MATRICIELLE OLIGOMERIQUE DU CARTILAGE -comp-, SONDE ANTIGENIQUE, ANTICORPS ET NECESSAIRE D'IMMUNOANALYSE UTILISE POUR LA MISE EN OEUVRE DE CE PROCEDE
US6849594B1 (en) 1999-06-30 2005-02-01 John Lawler Purification and use of human recombinant cartilage oligomeric matrix protein
SE9904236D0 (sv) * 1999-11-22 1999-11-22 Ana Mar Diagnostics Ab Immunoassay
US20030119074A1 (en) * 2001-12-20 2003-06-26 George Jackowski Diagnosis and treatment of dementia utilizing thrombospondin
JP2003307517A (ja) * 2002-04-16 2003-10-31 Inst Of Physical & Chemical Res Ｃｏｍｐ異常症の検査方法
US7655411B2 (en) * 2002-08-23 2010-02-02 W2 Holdings, Inc. Thrombospondin fragments and binding agents in the detection, diagnosis and evaluation of cancer
EP1766411B1 (de) * 2004-05-24 2011-02-23 AnaMar AB Verfahren zur bestimmung eines gewebeabbauverfahrens durch nachweis von comp-neoepitopen
WO2006044946A2 (en) * 2004-10-20 2006-04-27 Onco Detectors International, Llc Migration inhibitory factor in serum as a tumor marker for prostate, bladder, breast, ovarian, kidney and lung cancer
JP5237366B2 (ja) * 2007-06-20 2013-07-17 メルク・シャープ・アンド・ドーム・コーポレーション 炎症性関節疾患に対する抗ｉｌ−１７ａ治療のための関節破壊のバイオマーカー
AU2013281240B2 (en) 2012-06-28 2018-04-12 Nordic Bioscience A/S Determining pathological cartilage turnover
EP3015069A1 (de) 2014-10-30 2016-05-04 Universitätsklinikum Jena Vorrichtung für hängende Ultrasonografie und zugehöriges Verfahren

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8304836D0 (sv) * 1983-09-09 1983-09-09 Pharmacia Ab Sett att bestemma forendringar i ledbrosk
US4610960A (en) * 1983-12-21 1986-09-09 Wisconsin Alumni Research Foundation Monoclonal antibody to thrombospondin and method for assaying for and isolating thrombospondin
WO1995022765A1 (en) * 1994-02-19 1995-08-24 Seikagaku Kogyo Kabushiki Kaisha Method of assaying normal aglycan, assaying kit, and method of judging joint-related information
US5753230A (en) * 1994-03-18 1998-05-19 The Scripps Research Institute Methods and compositions useful for inhibition of angiogenesis
AUPM666894A0 (en) 1994-07-07 1994-07-28 University Of Melbourne, The Diagnostic methods and compositions

Also Published As

Publication number Publication date
JP4189033B2 (ja) 2008-12-03
US6589755B1 (en) 2003-07-08
EP0922225B1 (de) 2004-02-11
DE69727582D1 (de) 2004-03-18
EP0922225A1 (de) 1999-06-16
JP2000517418A (ja) 2000-12-26
WO1998007035A1 (en) 1998-02-19
AU4298297A (en) 1998-03-06
DE69727582T2 (de) 2004-12-23

Similar Documents

Publication Publication Date Title
US4732863A (en) PEG-modified antibody with reduced affinity for cell surface Fc receptors
Kemshead et al. Human Thy-1: Expression on the cell surface of neuronal and and glial cells
EP2853898B1 (de) Analyse von Myostatin im Serum
Hulten et al. A non-competitive chemiluminescence enzyme immunoassay for the equine acute phase protein serum amyloid A (SAA)–a clinically useful inflammatory marker in the horse
US8415107B2 (en) Thrombospondin fragments and binding agents in the detection, diagnosis and evaluation of cancer
DE69333641T2 (de) Methode zur messung der knochenresorption
DE69727582D1 (de) Test zur quantifizierung von arthritiszustanden
Takamori et al. Antibodies to recombinant synaptotagmin and calcium channel subtypes in Lambert-Eaton myasthenic syndrome
CA2524002A1 (en) Sars-related proteins
EP1577385A4 (de) Markerproteine zur diagnose einerlebererkrankung und verfahren zur diagnose einer lebererkrankung damit
US8663944B2 (en) Cartilage intermediate layer protein 2 C1 and its use to differentiate osteoarthritis from rheumatoid arthritis and non-disease conditions
DE69024043D1 (de) Monoklonaler antikörper mit erkennungsspezifität für ein glykoprotein des globulären membran-mucin-antigens aus menschlichem milchfett.
CA2348545A1 (en) A complex of a chaperone with .beta.-amyloid and methods employing this complex
US4826776A (en) Method for determining hyaluronic acid, and a reagent kit for said method
Afshar et al. Evaluation of a commercial competitive ELISA test kit for the detection of group-specific antibodies to bluetongue virus
CN1234730C (zh) 鼠抗氯霉素单克隆抗体及其用途
JP2019053068A (ja) 可溶型線維芽細胞増殖因子受容体の高感度多重イムノアッセイ
Jenkins et al. HPLC purification of recombinant NcGRA6 antigen improves enzyme-linked immunosorbent assay for serodiagnosis of bovine neosporosis
Akimoto et al. Relationship between clinical features and binding domains of anti-prothrombin autoantibodies in patients with systemic lupus erythematosus and antiphospholipid syndrome
DE69730223D1 (de) Diagnostische methode zum nachweis von isoformen des eosinophilen kationischen proteins
Nishifuji et al. Development of an enzyme‐linked immunosorbent assay for detection of circulating IgG autoantibodies against canine desmoglein 3 in dogs with pemphigus
JP4217717B2 (ja) 血清由来ヒアルロナン結合性タンパク質−ヒアルロン酸結合体の測定法および測定キット
US20080241945A1 (en) Peptide for differentiating osteoarthritis from rheumatoid arthritis and non-disease conditions
Kapogiannis et al. Differences in clinical sensitivity of ELISA tests for autoantibodies with human and bovine extractable nuclear antigens
JP4217716B2 (ja) 血清由来ヒアルロナン結合性タンパク質−ヒアルロン酸結合体の測定法および測定キット

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties